 | • レポートコード：GIR201100582 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、アミホスチンの世界市場を調査対象にし、アミホスチンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（400mg/回、500mg/回）、用途別分析（頭頸部がんアジュバント療法、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Clinigen、Merro Pharmaceutical、Sun Pharmaceutical、Taj Pharmaceuticals、Mingren Pharma、Luye Pharma ・メーカー別販売量、売上、市場シェア ・アミホスチンの地域別市場分析 ・アミホスチンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・アミホスチンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・アミホスチンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・アミホスチンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・アミホスチンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・アミホスチンの種類別市場規模2015-2020：400mg/回、500mg/回 ・アミホスチンの用途別市場規模2015-2020：頭頸部がんアジュバント療法、その他 ・アミホスチンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Amifostine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Amifostine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 56 million by 2025, from USD 52 million in 2019.
Market segmentation
Amifostine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Amifostine market has been segmented into
400mg/Dose
500mg/Dose
By Application, Amifostine has been segmented into:
Head and Neck Cancer Adjuvant Therapy
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Amifostine market presented in the report. This section sheds light on the sales growth of different regional and country-level Amifostine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Amifostine market.
The report offers in-depth assessment of the growth and other aspects of the Amifostine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Amifostine Market Share Analysis
Amifostine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Amifostine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Amifostine sales, revenue and market share for each player covered in this report.
The major players covered in Amifostine are:
Clinigen
Merro Pharmaceutical
Sun Pharmaceutical
Taj Pharmaceuticals
Mingren Pharma
Luye Pharma
Among other players domestic and global, Amifostine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Amifostine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Amifostine, with price, sales, revenue and global market share of Amifostine in 2018 and 2019.
Chapter 3, the Amifostine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Amifostine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Amifostine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Amifostine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Amifostine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Amifostine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 400mg/Dose
1.2.3 500mg/Dose
1.3 Market Analysis by Application
1.3.1 Overview: Global Amifostine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Head and Neck Cancer Adjuvant Therapy
1.3.3 Others
1.4 Overview of Global Amifostine Market
1.4.1 Global Amifostine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Clinigen
2.1.1 Clinigen Details
2.1.2 Clinigen Major Business
2.1.3 Clinigen SWOT Analysis
2.1.4 Clinigen Product and Services
2.1.5 Clinigen Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merro Pharmaceutical
2.2.1 Merro Pharmaceutical Details
2.2.2 Merro Pharmaceutical Major Business
2.2.3 Merro Pharmaceutical SWOT Analysis
2.2.4 Merro Pharmaceutical Product and Services
2.2.5 Merro Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sun Pharmaceutical
2.3.1 Sun Pharmaceutical Details
2.3.2 Sun Pharmaceutical Major Business
2.3.3 Sun Pharmaceutical SWOT Analysis
2.3.4 Sun Pharmaceutical Product and Services
2.3.5 Sun Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Taj Pharmaceuticals
2.4.1 Taj Pharmaceuticals Details
2.4.2 Taj Pharmaceuticals Major Business
2.4.3 Taj Pharmaceuticals SWOT Analysis
2.4.4 Taj Pharmaceuticals Product and Services
2.4.5 Taj Pharmaceuticals Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mingren Pharma
2.5.1 Mingren Pharma Details
2.5.2 Mingren Pharma Major Business
2.5.3 Mingren Pharma SWOT Analysis
2.5.4 Mingren Pharma Product and Services
2.5.5 Mingren Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Luye Pharma
2.6.1 Luye Pharma Details
2.6.2 Luye Pharma Major Business
2.6.3 Luye Pharma Product and Services
2.6.4 Luye Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Amifostine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Amifostine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Amifostine Manufacturer Market Share in 2019
3.3.2 Top 6 Amifostine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Amifostine Sales, Revenue and Market Share by Regions
4.1.1 Global Amifostine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Amifostine Revenue and Market Share by Regions (2015-2020)
4.2 North America Amifostine Sales and Growth Rate (2015-2020)
4.3 Europe Amifostine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Amifostine Sales and Growth Rate (2015-2020)
4.5 South America Amifostine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Amifostine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Amifostine Sales, Revenue and Market Share by Country
5.1.1 North America Amifostine Sales and Market Share by Country (2015-2020)
5.1.2 North America Amifostine Revenue and Market Share by Country (2015-2020)
5.2 United States Amifostine Sales and Growth Rate (2015-2020)
5.3 Canada Amifostine Sales and Growth Rate (2015-2020)
5.4 Mexico Amifostine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Amifostine Sales, Revenue and Market Share by Country
6.1.1 Europe Amifostine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Amifostine Revenue and Market Share by Country (2015-2020)
6.2 Germany Amifostine Sales and Growth Rate (2015-2020)
6.3 UK Amifostine Sales and Growth Rate (2015-2020)
6.4 France Amifostine Sales and Growth Rate (2015-2020)
6.5 Russia Amifostine Sales and Growth Rate (2015-2020)
6.6 Italy Amifostine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Amifostine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Amifostine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Amifostine Revenue and Market Share by Regions (2015-2020)
7.2 China Amifostine Sales and Growth Rate (2015-2020)
7.3 Japan Amifostine Sales and Growth Rate (2015-2020)
7.4 Korea Amifostine Sales and Growth Rate (2015-2020)
7.5 India Amifostine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Amifostine Sales and Growth Rate (2015-2020)
7.7 Australia Amifostine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Amifostine Sales, Revenue and Market Share by Country
8.1.1 South America Amifostine Sales and Market Share by Country (2015-2020)
8.1.2 South America Amifostine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Amifostine Sales and Growth Rate (2015-2020)
8.3 Argentina Amifostine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Amifostine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Amifostine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Amifostine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Amifostine Sales and Growth Rate (2015-2020)
9.3 Turkey Amifostine Sales and Growth Rate (2015-2020)
9.4 Egypt Amifostine Sales and Growth Rate (2015-2020)
9.5 South Africa Amifostine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Amifostine Sales and Market Share by Type (2015-2020)
10.2 Global Amifostine Revenue and Market Share by Type (2015-2020)
10.3 Global Amifostine Price by Type (2015-2020)
11 Global Amifostine Market Segment by Application
11.1 Global Amifostine Sales Market Share by Application (2015-2020)
11.2 Global Amifostine Revenue Market Share by Application (2015-2020)
11.3 Global Amifostine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Amifostine Sales, Revenue and Growth Rate (2021-2025)
12.2 Amifostine Market Forecast by Regions (2021-2025)
12.2.1 North America Amifostine Market Forecast (2021-2025)
12.2.2 Europe Amifostine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Amifostine Market Forecast (2021-2025)
12.2.4 South America Amifostine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Amifostine Market Forecast (2021-2025)
12.3 Amifostine Market Forecast by Type (2021-2025)
12.3.1 Global Amifostine Sales Forecast by Type (2021-2025)
12.3.2 Global Amifostine Market Share Forecast by Type (2021-2025)
12.4 Amifostine Market Forecast by Application (2021-2025)
12.4.1 Global Amifostine Sales Forecast by Application (2021-2025)
12.4.2 Global Amifostine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Amifostine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Amifostine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Amifostine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Amifostine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Clinigen Basic Information, Manufacturing Base and Competitors
Table 9. Clinigen Amifostine Major Business
Table 10. Clinigen Amifostine Total Revenue (USD Million) (2018-2019)
Table 11. Clinigen SWOT Analysis
Table 12. Clinigen Amifostine Product and Services
Table 13. Clinigen Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Merro Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 15. Merro Pharmaceutical Amifostine Major Business
Table 16. Merro Pharmaceutical Amifostine Total Revenue (USD Million) (2018-2019)
Table 17. Merro Pharmaceutical SWOT Analysis
Table 18. Merro Pharmaceutical Amifostine Product and Services
Table 19. Merro Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 21. Sun Pharmaceutical Amifostine Major Business
Table 22. Sun Pharmaceutical Amifostine Total Revenue (USD Million) (2018-2019)
Table 23. Sun Pharmaceutical SWOT Analysis
Table 24. Sun Pharmaceutical Amifostine Product and Services
Table 25. Sun Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 27. Taj Pharmaceuticals Amifostine Major Business
Table 28. Taj Pharmaceuticals Amifostine Total Revenue (USD Million) (2018-2019)
Table 29. Taj Pharmaceuticals SWOT Analysis
Table 30. Taj Pharmaceuticals Amifostine Product and Services
Table 31. Taj Pharmaceuticals Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Mingren Pharma Basic Information, Manufacturing Base and Competitors
Table 33. Mingren Pharma Amifostine Major Business
Table 34. Mingren Pharma Amifostine Total Revenue (USD Million) (2018-2019)
Table 35. Mingren Pharma SWOT Analysis
Table 36. Mingren Pharma Amifostine Product and Services
Table 37. Mingren Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Luye Pharma Amifostine Major Business
Table 40. Luye Pharma Amifostine Total Revenue (USD Million) (2018-2019)
Table 41. Luye Pharma SWOT Analysis
Table 42. Luye Pharma Amifostine Product and Services
Table 43. Luye Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Global Amifostine Sales by Manufacturer (2018-2019) (MT)
Table 45. Global Amifostine Revenue by Manufacturer (2018-2019) (USD Million)
Table 46. Global Amifostine Sales by Regions (2015-2020) (MT)
Table 47. Global Amifostine Sales Market Share by Regions (2015-2020)
Table 48. Global Amifostine Revenue by Regions (2015-2020) (USD Million)
Table 49. North America Amifostine Sales by Countries (2015-2020) (MT)
Table 50. North America Amifostine Sales Market Share by Countries (2015-2020)
Table 51. North America Amifostine Revenue by Countries (2015-2020) (USD Million)
Table 52. North America Amifostine Revenue Market Share by Countries (2015-2020)
Table 53. Europe Amifostine Sales by Countries (2015-2020) (MT)
Table 54. Europe Amifostine Sales Market Share by Countries (2015-2020)
Table 55. Europe Amifostine Revenue by Countries (2015-2020) (USD Million)
Table 56. Asia-Pacific Amifostine Sales by Regions (2015-2020) (MT)
Table 57. Asia-Pacific Amifostine Sales Market Share by Regions (2015-2020)
Table 58. Asia-Pacific Amifostine Revenue by Regions (2015-2020) (USD Million)
Table 59. South America Amifostine Sales by Countries (2015-2020) (MT)
Table 60. South America Amifostine Sales Market Share by Countries (2015-2020)
Table 61. South America Amifostine Revenue by Countries (2015-2020) (USD Million)
Table 62. South America Amifostine Revenue Market Share by Countries (2015-2020)
Table 63. Middle East & Africa Amifostine Sales by Countries (2015-2020) (MT)
Table 64. Middle East & Africa Amifostine Sales Market Share by Countries (2015-2020)
Table 65. Middle East & Africa Amifostine Revenue by Countries (2015-2020) (USD Million)
Table 66. Middle East & Africa Amifostine Revenue Market Share by Countries (2015-2020)
Table 67. Global Amifostine Sales by Type (2015-2020) (MT)
Table 68. Global Amifostine Sales Share by Type (2015-2020)
Table 69. Global Amifostine Revenue by Type (2015-2020) (USD Million)
Table 70. Global Amifostine Revenue Share by Type (2015-2020)
Table 71. Global Amifostine Sales by Application (2015-2020) (MT)
Table 72. Global Amifostine Sales Share by Application (2015-2020)
Table 73. Global Amifostine Sales Forecast by Regions (2021-2025) (MT)
Table 74. Global Amifostine Market Share Forecast by Regions (2021-2025)
Table 75. Global Amifostine Sales Forecast by Type (2021-2025) (MT)
Table 76. Global Amifostine Market Share Forecast by Type (2021-2025)
Table 77. Global Amifostine Sales Forecast by Application (2021-2025)
Table 78. Global Amifostine Market Share Forecast by Application (2021-2025)
Table 79. Direct Channel Pros & Cons
Table 80. Indirect Channel Pros & Cons
Table 81. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Amifostine Picture
Figure 2. Global Sales Market Share of Amifostine by Type in 2019
Figure 3. 400mg/Dose Picture
Figure 4. 500mg/Dose Picture
Figure 5. Amifostine Sales Market Share by Application in 2019
Figure 6. Head and Neck Cancer Adjuvant Therapy Picture
Figure 7. Others Picture
Figure 8. Global Amifostine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Amifostine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Amifostine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Amifostine Sales Market Share by Manufacturer in 2019
Figure 29. Global Amifostine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Amifostine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Amifostine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 34. Global Amifostine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Amifostine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Amifostine Revenue Market Share by Regions in 2018
Figure 37. North America Amifostine Sales and Growth Rate (2015-2020)
Figure 38. Europe Amifostine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Amifostine Sales and Growth Rate (2015-2020)
Figure 40. South America Amifostine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Amifostine Sales and Growth Rate (2015-2020)
Figure 42. North America Amifostine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Amifostine Sales Market Share by Countries (2015-2020)
Figure 44. North America Amifostine Sales Market Share by Countries in 2018
Figure 45. North America Amifostine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Amifostine Revenue Market Share by Countries in 2018
Figure 47. United States Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 48. Canada Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 49. Mexico Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 50. Europe Amifostine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Amifostine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Amifostine Revenue Market Share by Countries in 2019
Figure 53. Germany Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 54. UK Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 55. France Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 56. Russia Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 57. Italy Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 58. Asia-Pacific Amifostine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Amifostine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Amifostine Revenue Market Share by Regions 2019
Figure 61. China Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 62. Japan Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 63. Korea Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 64. India Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 65. Southeast Asia Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 66. South America Amifostine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Amifostine Sales Market Share by Countries in 2019
Figure 68. South America Amifostine Revenue Market Share by Countries in 2019
Figure 69. Brazil Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 70. Argentina Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 71. Middle East and Africa Amifostine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Amifostine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Amifostine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Amifostine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 76. Egypt Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 77. Turkey Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 78. South Africa Amifostine Sales and Growth Rate (2015-2020) (MT)
Figure 79. Global Amifostine Sales and Growth Rate (2021-2025) (MT)
Figure 80. Global Amifostine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Amifostine Market Forecast (2021-2025) (MT)
Figure 82. Europe Sales Amifostine Market Forecast (2021-2025) (MT)
Figure 83. Asia-Pacific Sales Amifostine Market Forecast (2021-2025) (MT)
Figure 84. South America Sales Amifostine Market Forecast (2021-2025) (MT)
Figure 85. Middle East & Africa Sales Amifostine Market Forecast (2021-2025) (MT)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
頭頸部扁平上皮がん治療の世界市場 2020年 Market Overview The global Head And Neck Squamous Cell Carcinoma Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…- 放射線量管理サービスの世界市場 2020年 Market Overview The global Radiation Dose Management Service market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Radiation D…
- パニツムマブの世界市場 2020年 Market Overview The global Panitumumab market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Panitumumab market report provide…
- がん治療における感染管理の世界市場 2020年 Market Overview The global Infection Control in Cancer Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Infection…
- セルトリズマブペゴルの世界市場 2020年 Market Overview The global Certolizumab pegol market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Certolizumab pegol market …